A detailed history of Red Wave Investments LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Red Wave Investments LLC holds 2,980 shares of ABBV stock, worth $491,670. This represents 0.23% of its overall portfolio holdings.

Number of Shares
2,980
Previous 2,994 0.47%
Holding current value
$491,670
Previous $513,000 14.62%
% of portfolio
0.23%
Previous 0.2%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $2,293 - $2,790
-14 Reduced 0.47%
2,980 $588,000
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $6,346 - $7,411
-41 Reduced 1.35%
2,994 $513,000
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $2,716 - $3,095
17 Added 0.56%
3,035 $552,000
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $1,100 - $1,239
8 Added 0.27%
3,018 $467,000
Q3 2023

Nov 07, 2023

SELL
$133.59 - $154.65 $133 - $154
-1 Reduced 0.03%
3,010 $448,000
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $13,383 - $16,654
101 Added 3.47%
3,011 $405,000
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $10,267 - $11,824
71 Added 2.5%
2,910 $463,000
Q4 2022

Feb 03, 2023

SELL
$138.31 - $165.87 $128,904 - $154,590
-932 Reduced 24.71%
2,839 $459,000
Q3 2022

Nov 02, 2022

BUY
$134.21 - $153.93 $7,247 - $8,312
54 Added 1.45%
3,771 $506,000
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $14,037 - $17,845
-102 Reduced 2.67%
3,717 $569,000
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $84,335 - $104,636
639 Added 20.09%
3,819 $619,000
Q4 2021

Feb 07, 2022

SELL
$107.43 - $135.93 $10,743 - $13,593
-100 Reduced 3.05%
3,180 $431,000
Q3 2021

Oct 21, 2021

SELL
$106.4 - $120.78 $2,766 - $3,140
-26 Reduced 0.79%
3,280 $354,000
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $1,998 - $2,226
19 Added 0.58%
3,306 $372,000
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $7,161 - $7,883
70 Added 2.18%
3,287 $356,000
Q4 2020

Feb 17, 2021

BUY
$80.49 - $108.67 $258,936 - $349,591
3,217 New
3,217 $345,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Red Wave Investments LLC Portfolio

Follow Red Wave Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Wave Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Wave Investments LLC with notifications on news.